There’s been talk for several months that the UK CBD industry needs better regulation, and now a trade association has been created to do just that.
The Association for the Cannabinoid Industry (ACI) was officially launched on November 8, at the Centre for Medicinal Cannabis conference.
The association is a platform designed to bring together scientists and business leaders in the CBD industry. Its aim is to create a mutually-beneficial industry that’s both within the law and innovative, while ensuring customer safety.
One of the ambitions of the ACI is to create a Quality Charter, to help guide companies through the somewhat complex legal compliance system. To help do this it has partnered with Global Regulatory Services – award-winning regulatory consultants.
Ultimately it hopes to introduce a new kitemark to appear on products that meet its standards and assurance on quality and safety.
“This new initiative exists to ensure that our members are fully compliant to an agreed set of terms with the relevant regularly bodies, ensuring consumer can continue to access legal, safe and quality CBD products,” says Dr Andy Yates, CMC Pharmacy Lead. “Those who sign up to the ACI Charter will need to put their products under intense, but necessary scrutiny, analysing manufacturing process, assessing claims and using where required toxicology studies to prove a product is safe.”
As we’ve previously covered, this comes off the back of a six-month report into the industry by the Centre for Medical Cannabis that reached several damning conclusions. One of these was that more than half of high street CBD products didn’t contain what was written on the label, as well as the discovery of a £90 product that contained no CBD at all. · Read more about the report here https://elixinol.eu/en/blog/things-are-changing-in-the-uks-cbd-regulations/
As a company that works hard on compliance and safety, we naturally welcome the formation of this association, and look forward to its positive effects on the industry.